NLRP3 and metabolic dysfunction-associated steatotic liver disease: In addition, NAFLD hepatic sEVs enhanced the cardiac content of HMGB1 and IL-1β in NLRP3+/+ mice but not NLRP3−/− mice (Additional file 1: Fig. S5A–D).